We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+1.69%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$22.4B
AUM Growth
+$745M
Cap. Flow
+$687M
Cap. Flow %
3.07%
Top 10 Hldgs %
31.51%
Holding
1,352
New
72
Increased
666
Reduced
342
Closed
71

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$191M
2
MSFT icon
Microsoft
MSFT
+$116M
3
NVDA icon
NVIDIA
NVDA
+$115M
4
AAPL icon
Apple
AAPL
+$108M
5
WY icon
Weyerhaeuser
WY
+$83.8M

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$118M
2
DLR icon
Digital Realty Trust
DLR
+$106M
3
CCI icon
Crown Castle
CCI
+$104M
4
SPG icon
Simon Property Group
SPG
+$93M
5
KIM icon
Kimco Realty
KIM
+$64.5M

Sector Composition

Rank Sector Weight
1 Real Estate 37.54%
2 Technology 23.33%
3 Communication Services 8.01%
4 Consumer Discretionary 6.37%
5 Financials 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XNCR icon
1151
Xencor
XNCR
$1.48B
$5K ﹤0.01%
222
– –
ANIP icon
1152
ANI Pharmaceuticals
ANIP
$1.84B
$4K ﹤0.01%
70
– –
ARDX icon
1153
Ardelyx
ARDX
$1.26B
$4K ﹤0.01%
754
– –
COLL icon
1154
Collegium Pharmaceutical
COLL
$1.16B
$4K ﹤0.01%
127
– –
DAWN
1155
DELISTED
Day One Biopharmaceuticals
DAWN
$4K ﹤0.01%
296
– –
DBC icon
1156
Invesco DB Commodity Index Tracking Fund
DBC
$1.65B
$4K ﹤0.01%
200
– –
HROW icon
1157
Harrow
HROW
$1.47B
$4K ﹤0.01%
110
– –
IMCR icon
1158
Immunocore
IMCR
$1.7B
$4K ﹤0.01%
138
– –
INVA icon
1159
Innoviva
INVA
$1.61B
$4K ﹤0.01%
238
– –
RCKT icon
1160
Rocket Pharmaceuticals
RCKT
$343M
$4K ﹤0.01%
304
– –
SNDX icon
1161
Syndax Pharmaceuticals
SNDX
$1.74B
$4K ﹤0.01%
314
– –
SPRY icon
1162
ARS Pharmaceuticals
SPRY
$563M
$4K ﹤0.01%
367
– –
TVTX icon
1163
Travere Therapeutics
TVTX
$5.2B
$4K ﹤0.01%
258
– –
VIR icon
1164
Vir Biotechnology
VIR
$1.49B
$4K ﹤0.01%
535
– –
XLF icon
1165
State Street Financial Select Sector SPDR ETF
XLF
$57.4B
$4K ﹤0.01%
78
-56
-42% -$2.71K
ZYME icon
1166
Zymeworks
ZYME
$1.66B
$4K ﹤0.01%
286
– –
ABCL icon
1167
AbCellera Biologics
ABCL
$1.62B
$3K ﹤0.01%
1,151
– –
ADPT icon
1168
Adaptive Biotechnologies
ADPT
$3.6B
$3K ﹤0.01%
530
– –
AVDL
1169
DELISTED
Avadel Pharmaceuticals
AVDL
$3K ﹤0.01%
332
– –
AVXL icon
1170
Anavex Life Sciences
AVXL
$238M
$3K ﹤0.01%
314
– –
CGEM icon
1171
Cullinan Oncology
CGEM
$1.07B
$3K ﹤0.01%
218
– –
COGT icon
1172
Cogent Biosciences
COGT
$6.95B
$3K ﹤0.01%
416
– –
ELVN icon
1173
Enliven Therapeutics
ELVN
$3.84B
$3K ﹤0.01%
152
– –
EOLS icon
1174
Evolus
EOLS
$410M
$3K ﹤0.01%
262
– –
ERAS icon
1175
Erasca
ERAS
$6.3B
$3K ﹤0.01%
1,074
– –
45 46
47
48 49

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q4 2024 Portfolio in Review

As of Q4 2024, Daiwa Securities Group held 1,352 positions worth $22.4B, up 3.4% from $21.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Daiwa Securities Group deployed $687M of net new capital in Q4 2024, opening 72 new positions and adding to 666 existing holdings. Its largest new stake was Curbline Properties: 2,033,334 shares worth $47.2M.

By sector, the portfolio is most concentrated in Real Estate at 38% of assets, down from 42% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $118M trimmed.

  • Daiwa Securities Group's largest Q4 2024 buy was Curbline Properties: 2,033,334 shares worth $47.2M.
  • Daiwa Securities Group added most to American Tower in Q4 2024, an estimated $191M increase.
  • Daiwa Securities Group's biggest Q4 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $118M.
  • Daiwa Securities Group fully exited State Street SPDR S&P 500 ETF Trust in Q4 2024, selling an estimated $10.3M.
  • Daiwa Securities Group's ten largest holdings make up 32% of its $22.4B portfolio in Q4 2024.
  • Daiwa Securities Group opened 72 new positions and closed 71 in Q4 2024.
  • Daiwa Securities Group's portfolio value rose 3.4% quarter-over-quarter to $22.4B.

Based on Daiwa Securities Group's 13F filing for Q4 2024, filed 7 Feb 2025.